Causes of Death in Patients with Laryngeal Cancer in Stages I and II

Detalhes bibliográficos
Autor(a) principal: Matos, José Pedro
Data de Publicação: 2012
Outros Autores: Castro Silva, Joaquim, Monteiro, Eurico
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/293
Resumo: Background: Laryngeal carcinoma is one of the most common cancers in the head and neck region and occurs predominantly in males. The peak of incidence is between 50 and 70 years of life. The glottis is the most affected topography, but in the Mediterranean countries the supraglottic region assumes a particular preponderance. In the early stages of the disease, the survival rate at 5 years is of about 90% (stage I). The most important risk factors for this tumor are alcohol and tobacco consumption and these patients, probably because of their lifestyle, have several associated comorbidities. Objectives: To frame the survival rates related to the disease, not disease related and also those arising from other malignancies, allowing to criticize some published data. Methods: From the analysis of medical records of patients diagnosed with laryngeal cancer in stages I and II, treated from 2000 to 2005, the cause of death in these patients was analysed. Results: A total of 216 clinical records were reviewed. It was observed that the overall survival of patients in the study period was 75% and that 66.7% and 54.5% of the deaths were not related to the disease, respectively, for stages I and II. It was also found that the specific survival rate for stage I was 94.6% and for stage II was 90.3%. Conclusion: The results show that most patients’ deaths were not related to laryngeal cancer. Thus, the authors emphasize the importance of a careful analysis of statistical data on rates of survival / mortality for cancers of the larynx, especially in the early stages.
id RCAP_d5ac5e46e86b7565ae7a089afa71798d
oai_identifier_str oai:ojs.www.actamedicaportuguesa.com:article/293
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Causes of Death in Patients with Laryngeal Cancer in Stages I and IICausas de Morte nos Doentes com Neoplasia da Laringe nos Estádios I e IIBackground: Laryngeal carcinoma is one of the most common cancers in the head and neck region and occurs predominantly in males. The peak of incidence is between 50 and 70 years of life. The glottis is the most affected topography, but in the Mediterranean countries the supraglottic region assumes a particular preponderance. In the early stages of the disease, the survival rate at 5 years is of about 90% (stage I). The most important risk factors for this tumor are alcohol and tobacco consumption and these patients, probably because of their lifestyle, have several associated comorbidities. Objectives: To frame the survival rates related to the disease, not disease related and also those arising from other malignancies, allowing to criticize some published data. Methods: From the analysis of medical records of patients diagnosed with laryngeal cancer in stages I and II, treated from 2000 to 2005, the cause of death in these patients was analysed. Results: A total of 216 clinical records were reviewed. It was observed that the overall survival of patients in the study period was 75% and that 66.7% and 54.5% of the deaths were not related to the disease, respectively, for stages I and II. It was also found that the specific survival rate for stage I was 94.6% and for stage II was 90.3%. Conclusion: The results show that most patients’ deaths were not related to laryngeal cancer. Thus, the authors emphasize the importance of a careful analysis of statistical data on rates of survival / mortality for cancers of the larynx, especially in the early stages.Introdução: O carcinoma da laringe é uma das neoplasias mais frequentes na região da cabeça e pescoço e ocorre predominantemente no sexo masculino. O pico da incidência situa-se entre os 50 e os 70 anos de vida. A região glótica é a mais afectada, mas nos países mediterrânicos, estes tumores podem exprimir-se mais na região supraglótica. Nos estádios precoces da doença, a taxa de sobrevivência aos cinco anos é de cerca de 90% (estádio I). Os factores de risco mais importantes para esta neoplasia são o consumo de álcool e de tabaco, sendo que, estes doentes, provavelmente pelo seu estilo de vida, apresentam várias comorbilidades associadas. Objectivo: Enquadrar as taxas de sobrevivência relacionadas com a doença, com as não relacionadas com a doença e ainda as decorrentes de outras neoplasias, permitindo criticar dados estatísticos publicados. Métodos: A partir da análise dos processos clínicos dos doentes com diagnóstico de carcinoma da laringe estádios I e II, tratados entre 2000 e 2005, procurou-se analisar a causa de morte desses doentes. Resultados: Foram consultados os processos clínicos de 216 doentes. Observou-se que a sobrevivência global dos doentes, no período estudado, foi de 75%, sendo que 66,7% e 54,5 % das mortes não estavam relacionadas com a doença, respectivamente, para os estádios I e II. Constatou-se também que a sobrevivência específica para o estádio I foi de 94,6% e para o estádio II de 90,3%. Conclusão: Os resultados obtidos revelam que grande parte das mortes dos doentes não estava relacionada com a neoplasia laríngea. Deste modo, os autores enfatizam a importância de uma criteriosa análise dos dados estatísticos relativos às taxas de sobrevivência / mortalidade para as neoplasias da laringe, especialmente nos estádios precoces.Ordem dos Médicos2012-11-12info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/x-pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/293oai:ojs.www.actamedicaportuguesa.com:article/293Acta Médica Portuguesa; Vol. 25 No. 5 (2012): September-October; 317-322Acta Médica Portuguesa; Vol. 25 N.º 5 (2012): Setembro-Outubro; 317-3221646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/293https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/293/86Matos, José PedroCastro Silva, JoaquimMonteiro, Euricoinfo:eu-repo/semantics/openAccess2022-12-20T10:55:59Zoai:ojs.www.actamedicaportuguesa.com:article/293Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:16:27.310352Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Causes of Death in Patients with Laryngeal Cancer in Stages I and II
Causas de Morte nos Doentes com Neoplasia da Laringe nos Estádios I e II
title Causes of Death in Patients with Laryngeal Cancer in Stages I and II
spellingShingle Causes of Death in Patients with Laryngeal Cancer in Stages I and II
Matos, José Pedro
title_short Causes of Death in Patients with Laryngeal Cancer in Stages I and II
title_full Causes of Death in Patients with Laryngeal Cancer in Stages I and II
title_fullStr Causes of Death in Patients with Laryngeal Cancer in Stages I and II
title_full_unstemmed Causes of Death in Patients with Laryngeal Cancer in Stages I and II
title_sort Causes of Death in Patients with Laryngeal Cancer in Stages I and II
author Matos, José Pedro
author_facet Matos, José Pedro
Castro Silva, Joaquim
Monteiro, Eurico
author_role author
author2 Castro Silva, Joaquim
Monteiro, Eurico
author2_role author
author
dc.contributor.author.fl_str_mv Matos, José Pedro
Castro Silva, Joaquim
Monteiro, Eurico
description Background: Laryngeal carcinoma is one of the most common cancers in the head and neck region and occurs predominantly in males. The peak of incidence is between 50 and 70 years of life. The glottis is the most affected topography, but in the Mediterranean countries the supraglottic region assumes a particular preponderance. In the early stages of the disease, the survival rate at 5 years is of about 90% (stage I). The most important risk factors for this tumor are alcohol and tobacco consumption and these patients, probably because of their lifestyle, have several associated comorbidities. Objectives: To frame the survival rates related to the disease, not disease related and also those arising from other malignancies, allowing to criticize some published data. Methods: From the analysis of medical records of patients diagnosed with laryngeal cancer in stages I and II, treated from 2000 to 2005, the cause of death in these patients was analysed. Results: A total of 216 clinical records were reviewed. It was observed that the overall survival of patients in the study period was 75% and that 66.7% and 54.5% of the deaths were not related to the disease, respectively, for stages I and II. It was also found that the specific survival rate for stage I was 94.6% and for stage II was 90.3%. Conclusion: The results show that most patients’ deaths were not related to laryngeal cancer. Thus, the authors emphasize the importance of a careful analysis of statistical data on rates of survival / mortality for cancers of the larynx, especially in the early stages.
publishDate 2012
dc.date.none.fl_str_mv 2012-11-12
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/293
oai:ojs.www.actamedicaportuguesa.com:article/293
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/293
identifier_str_mv oai:ojs.www.actamedicaportuguesa.com:article/293
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/293
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/293/86
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/x-pdf
dc.publisher.none.fl_str_mv Ordem dos Médicos
publisher.none.fl_str_mv Ordem dos Médicos
dc.source.none.fl_str_mv Acta Médica Portuguesa; Vol. 25 No. 5 (2012): September-October; 317-322
Acta Médica Portuguesa; Vol. 25 N.º 5 (2012): Setembro-Outubro; 317-322
1646-0758
0870-399X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130618450149376